200,000+ products from a single source!
sales@angenechem.com
Home > Pyridines > 158942-04-2
158942-04-2 | Benzo[1,2-b:4,5-b']dipyrrole-1(2H)-carboxamide, 3,5-dihydro-5-methyl-N-3-pyridinyl-
CAS No: 158942-04-2 Catalog No: AG001R11 MDL No:
Product Description
Catalog Number:
AG001R11
Chemical Name:
Benzo[1,2-b:4,5-b']dipyrrole-1(2H)-carboxamide, 3,5-dihydro-5-methyl-N-3-pyridinyl-
CAS Number:
158942-04-2
Molecular Formula:
C17H16N4O
Molecular Weight:
292.3351
IUPAC Name:
1-methyl-N-pyridin-3-yl-6,7-dihydropyrrolo[2,3-f]indole-5-carboxamide
InChI:
InChI=1S/C17H16N4O/c1-20-7-4-12-10-16-13(9-15(12)20)5-8-21(16)17(22)19-14-3-2-6-18-11-14/h2-4,6-7,9-11H,5,8H2,1H3,(H,19,22)
InChI Key:
QJQORSLQNXDVGE-UHFFFAOYSA-N
SMILES:
O=C(N1CCc2c1cc1ccn(c1c2)C)Nc1cccnc1
UNII:
AL4387525T
Properties
Complexity:
429
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
292.132g/mol
Formal Charge:
0
Heavy Atom Count:
22
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
292.342g/mol
Monoisotopic Mass:
292.132g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
50.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.7
Literature
| Title | Journal |
|---|---|
| Identification of potent Yes1 kinase inhibitors using a library screening approach. | Bioorganic & medicinal chemistry letters 20130801 |
| Serotonin-induced brain glycogenolysis in rainbow trout (Oncorhynchus mykiss). | The Journal of experimental biology 20120901 |
| Diverse effects of 5-HT2C receptor blocking agents on c-Fos expression in the rat basal ganglia. | European journal of pharmacology 20120815 |
| Paroxetine-induced reduction of sexual incentive motivation in female rats is not modified by 5-HT1B or 5-HT2C antagonists. | Psychopharmacology 20120301 |
| A novel mechanism for regulating hepatic glycogen synthesis involving serotonin and cyclin-dependent kinase-5. | Diabetes 20120101 |
| SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats. | BMC neuroscience 20120101 |
| Discovery and development of α7 nicotinic acetylcholine receptor modulators. | Journal of medicinal chemistry 20111208 |
| Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus. | American journal of physiology. Lung cellular and molecular physiology 20111201 |
| Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats. | European journal of pharmacology 20110520 |
| Blockade of 5-HT(2A) and/or 5-HT(2C) receptors modulates sevoflurane-induced immobility. | Journal of anesthesia 20110401 |
| Serotonin 2A and 2B receptor-induced phrenic motor facilitation: differential requirement for spinal NADPH oxidase activity. | Neuroscience 20110331 |
| Serotonin receptor 5-HT2B mediates serotonin-induced mechanical hyperalgesia. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110126 |
| Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization. | Pharmacological reports : PR 20110101 |
| Locomotion after spinal cord injury depends on constitutive activity in serotonin receptors. | Journal of neurophysiology 20101201 |
| Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs. | Journal of medicinal chemistry 20101111 |
| Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants. | Molecular pharmacology 20101101 |
| The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity. | Journal of neurochemistry 20100901 |
| The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen. | Psychopharmacology 20100401 |
| Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure. | Behavioural pharmacology 20100301 |
| 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease. | Neuropharmacology 20100101 |
| Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors. | Bioorganic & medicinal chemistry letters 20091201 |
| In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. | Journal of neurochemistry 20091001 |
| Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity. | The European journal of neuroscience 20090701 |
| Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide). | The Journal of pharmacology and experimental therapeutics 20090301 |
| Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat. | Psychopharmacology 20081101 |
| Ontogeny of serotonin and serotonin2A receptors in rat auditory cortex. | Hearing research 20081001 |
| 5HT2 receptor activation facilitates P2X receptor mediated excitatory neurotransmission to cardiac vagal neurons in the nucleus ambiguus. | Neuropharmacology 20080601 |
| Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. | Molecular pharmacology 20080301 |
| Identification of a key amino acid of the human 5-HT(2B) serotonin receptor important for sarpogrelate binding. | Journal of pharmacological sciences 20070701 |
| WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity. | The Journal of pharmacology and experimental therapeutics 20070101 |
| Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neonates. | Brain research 20060927 |
| 5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats. | Psychopharmacology 20060401 |
| Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo. | Biological psychiatry 20060315 |
| Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats. | Psychopharmacology 20051001 |
| Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901 |
| Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action. | Pharmacology, biochemistry, and behavior 20050701 |
| Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. | Progress in neuro-psychopharmacology & biological psychiatry 20050601 |
| Modulation of dopamine release by striatal 5-HT2C receptors. | Synapse (New York, N.Y.) 20050315 |
| Partial 5-HT(1A) receptor agonist activity by the 5-HT(2C) receptor antagonist SB 206,553 is revealed in rats spinalized as neonates. | Experimental neurology 20050201 |
| The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. | British journal of pharmacology 20041101 |
| Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release. | Journal of neurochemistry 20041101 |
| Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones. | British journal of pharmacology 20041001 |
| Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. | Circulation 20040824 |
| Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. | Naunyn-Schmiedeberg's archives of pharmacology 20040801 |
| Effect of estrogen on the lordosis-inhibiting action of ketanserin and SB 206553. | Behavioural brain research 20040604 |
| Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats. | Pharmacology 20040601 |
| Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20040331 |
| In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040201 |
| Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats. | Psychopharmacology 20031001 |
| Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes. | Behavioral neuroscience 20030401 |
| Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. | Behavioural brain research 20030318 |
| Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP. | Behavioural pharmacology 20030301 |
| Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice. | Psychopharmacology 20030201 |
| Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel 'locked-on' phenotype and double revertant mutations. | The Journal of biological chemistry 20020927 |
| Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat. | Naunyn-Schmiedeberg's archives of pharmacology 20020801 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin. | Neurochemistry international 20020301 |
| Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020101 |
| Effects of 5-HT(2) receptor antagonists on the anti-immobility effects of imipramine in the forced swimming test with mice. | European journal of pharmacology 20010921 |
| Role of 5-HT(2) receptor subtypes in depletion of 5-HT induced by p-chloroamphetamine in the mouse frontal cortex. | Brain research 20010824 |
| Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20010501 |
| Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010301 |
| Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19990601 |
| Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors. | European journal of pharmacology 19970305 |
| In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. | British journal of pharmacology 19960201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.